Navigation Links
A new screening test for chronic abdominal pain
Date:12/29/2008

Evaluation of chronic abdominal pain of luminal etiology is a challenging problem for the primary care physicians and gastroenterologists. The exact localization of lesion to either small or large bowel remains an elusive identity in many subjects. In tropical countries, where most of the population is of low socioeconomic status, one needs an imaging modality which screens small and large bowel lesions simultaneously at a reasonable cost with good sensitivity and specificity. Small bowel evaluation by BMFT and colonic evaluation by double contrast barium enema (DCBE) are the standard norms but doing them separately adds cost as well as discomfort to the patient. Pneumocolon has been combined with BMFT in previous studies for evaluation of ileocecal lesions but not as a screening modality for both small and large bowel simultaneously.

A research article to be published on November 21, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Prof. Nijhawan from SMS Medical College and Hospital, Jaipur, India tried to evaluate BMFTP as a screening tool for subjects with chronic abdominal pain of luminal origin where site of involvement (small or large bowel) is not well known based on clinical history.

This study revealed that adding pneumocolon to the BMFT can not only image ileo-cecal area better but also detect colonic lesions if present thereby obviating the need of doing Barium enema separately. Only subjects with strong suspicion of having recto-sigmoid lesions or having lesions depicted on BMFTP can then be taken for colonoscopy, thereby cutting down the overall cost to a large extent.

Based on the results of this study, the authors have proposed a step up approach of screening subjects with chronic abdominal pain of luminal origin. Following this approach, one would be able to pick up most of the subjects with underlying structural lesions and that too at a reasonable cost which is an
'/>"/>

Contact: Lin Tian
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. FDA Approves New Roche West Nile Virus Blood Screening Test
2. New lung cancer guidelines oppose general CT screening
3. New Lung Cancer Guidelines Oppose General CT Screening
4. Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
5. Screening Proposed for Childhood Cholesterol Levels
6. A new technology for cancer screening listens for the signs of cancer
7. Study Questions Genetic Screening for Treatable Diseases
8. Cervical cancer screening: Too many are left unprotected
9. Simple, personalized interventions improve colorectal cancer screening rates
10. Doctors Office Outreach Boosts Colon Cancer Screening
11. Jefferson researchers find personalized interventions key to improving colon cancer screening rates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ulti-purpose bilingual coloring books designed for...siness community to educate - inform parents and c... issues to Dinosuars to ABC,S and a host of other ... (PRWEB) November 27, 2009 -- Today’s childr...p them busy any hour of the day, but one of the ol...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
(Date:11/25/2009)...alif., Nov. 25 Onyx Ph...ed that the company will host two investor events ...ber 7, 2009 - 9:00 a.m. CT/10:00 a.m. ET ,, P...ions surrounding carfilzomib in relapsed and/or re... American Society of Hematology (ASH) Annual Meeti...
Breaking Medicine News(10 mins):Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...fer Gilson & Lione, one of,the largest intellectua...nounce that Jacob Cheung-Ka Ong has joined the fir..., Jacob Cheung-Ka Ong received a B.S. in neurosci...m the J. Reuben,Clark School of Law, Brigham Young...
...rates continue to improve for children under the a...c leukemia (ALL), acute non-lymphoblastic leukemia...es, researchers report in the September 9 online i...m survival in these patients. However, most popula...
...lial Risk Estimates Increases Estimated Melanoma R...elative risk of familial melanoma increases substa...tial bias in a large cohort study. The relative ri...cer Registry and the Swedish MultiGenerational Reg...
...ant women who take high levels of daily calcium su...n their blood, suggesting calcium could play a cri..., A new study at the University of Michigan shows...ose with high bone lead levels showed the largest ...
...2008) Both higher fish consumption and longer bre...tive development in infants, according to a study ... consumption and longer breastfeeding were indepen...ce that moderate maternal fish intake during pregn...
... be given in tandem with clot-dissolving drug , ...safe to give the clot-dissolving drug tPA to peopl...ffered a stroke, a new study indicates. , The Amer...re was no evidence to support that," said study le...
Other Medicine News:Health News:5- and 10-year survival continues to improve for US children with hematologic malignancies 2Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Calcium during pregnancy reduces harmful blood lead levels 2Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 2Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 3Health News:Blood Pressure Treatment Can Be Used Against Stroke 2
(Date:11/25/2009)...ANOGA PARK, Calif., Nov. 25 Praxis...ankings in the American Academy of Family Physicia...HR User Satisfaction Survey for improving medical ...t, all critical for new ARRA Stimulus legislation....eir EMR had a positive effect in determining their...
(Date:11/25/2009)...LOVELAND, Colo., Nov. 25 ...rovider of advanced diagnostic and specialty pro...agreements with Roche Diagnostics Corporation for ...nsumables for the veterinary market. ,, (Log...HESKALOGO ) ,, "Heska and Roche share the same ...
(Date:11/25/2009)...INCETON, N.J., Nov. 25 P... pharmaceutical company committed to discovering, ...t viral infections, reported financial results for...ember 30, 2009 Pharmasset held $58.4 million in ca...,, Pipeline Update and 2009 Highlights ,, ...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 1New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 2New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 3New Collaborations and Breakthrough Advancements in RNA Based Drug Development Programs Lead Santaris Pharma A S to Establish US Operations 14077 4Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 1Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 2Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 3Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 4Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 5Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 6Los Angeles Dentist Dr Sam Muslin Receives LAs Best Award 2009 57313 7Silk Partners With Celebrity Fitness Expert Gunnar Peterson to Promote Heart Health 57309 1Silk Partners With Celebrity Fitness Expert Gunnar Peterson to Promote Heart Health 57309 2Silk Partners With Celebrity Fitness Expert Gunnar Peterson to Promote Heart Health 57309 3
...Texas--(BUSINESS WIRE)--Jun 11, 2007 - Opexa,Thera... the,development and commercialization of cell the...ual Meeting of the Federation of,Clinical Immunolo...,Sheraton San Diego Hotel & Marina. The poster...Peptides in Relapsing,Remitting Multiple Sclerosis...
...t the Congress of the European Hematology,Associat...l/ -- Favrille,Inc. , a biopharmaceutical company...es for the treatment of cancer, announced,interim ...patients,with indolent B-cell non-Hodgkin,s lympho...f the European Hematology Association in,Vienna on...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3
Inorganic Phosphorus UV Reagent Set
Phosphorus Reagent
Amylase (EPS-G7, kinetics)
Amylase (Colorimetric Method)
Medicine Products: